Vitamin D Supplementation Guidelines

Assessment of Vitamin D Status

A 25(OH)D level of 21.3 ng/mL indicates vitamin D insufficiency, as levels below 30 ng/mL are considered suboptimal and warrant supplementation, according to the American Journal of Kidney Diseases 1, 3
This level of insufficiency is associated with increased risk of secondary hyperparathyroidism, reduced bone mineral density, and higher fracture risk, as reported by the American Journal of Kidney Diseases 2
Vitamin D insufficiency is common, with approximately 77% of the US population having levels less than 30 ng/mL, as stated by a medical journal, not Praxis Medical Insights, but the exact journal is not specified in this context, however it is mentioned in the original text as 4

Initiating vitamin D supplementation at this level is safe without prior knowledge of PTH levels or urine calcium excretion, as recommended by the American Journal of Kidney Diseases 1, 2
For patients with 25(OH)D levels between 20-30 ng/mL, vitamin D supplementation has been shown to be safe and effective in improving vitamin D status, according to the American Journal of Kidney Diseases, however the exact citation is not provided in this context, but it is mentioned in the original text as 2
The risk of adverse effects from standard vitamin D supplementation at this level of insufficiency is minimal, as reported by the American Journal of Kidney Diseases 2, 5

For a 25(OH)D level of 21.3 ng/mL, supplementation with ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) is recommended, according to the American Journal of Kidney Diseases 1, 2
Standard supplementation options include daily supplementation with 800-1000 IU/day of vitamin D, as recommended by Autoimmunity Reviews 6, 7
Monthly supplementation with 50,000 IU capsule (equivalent to approximately 1600 IU/day) is also an option, as reported by the American Journal of Kidney Diseases 2, 5
Higher dose supplementation (700-1000 IU/day) has been shown to reduce falls by 19% and fracture risk by 20%, according to Autoimmunity Reviews 6, 7

After initiating vitamin D supplementation, measure serum calcium and phosphorus every 3 months, as recommended by the American Journal of Kidney Diseases 1, 3
Discontinue vitamin D therapy if serum calcium exceeds 10.2 mg/dL, as reported by the American Journal of Kidney Diseases 1, 8
Discontinue vitamin D therapy if serum phosphorus exceeds 4.6 mg/dL and remains elevated despite phosphate binder therapy, according to the American Journal of Kidney Diseases 1, 8
Once vitamin D repletion is achieved (levels >30 ng/mL), continue maintenance supplementation and reassess 25(OH)D levels annually, as recommended by the American Journal of Kidney Diseases 1, 3

The goal of supplementation is to achieve and maintain 25(OH)D levels of at least 30 ng/mL, as recommended by the American Journal of Kidney Diseases 1, 2
Some evidence suggests that levels of 30-40 ng/mL may be optimal for musculoskeletal health and fall prevention, according to Autoimmunity Reviews 6, 7
Benefits for fall prevention are seen at levels of at least 24 ng/mL, and fracture prevention at levels of at least 30 ng/mL, as reported by Autoimmunity Reviews 6